6
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T80968 | Topoisomerase I inhibitor 10 | Topoisomerase | DNA Damage/DNA Repair |
TopoisomeraseI inhibitor 10 (compound 13)为一种抗利什曼原虫活性药物,特别针对L. donovani promastigotes的leishmanial topoisomerase IB表现出抑制作用,IC50值为27.91 μM。 | |||
T60123 |
Chimmitecan
(S)-9-Allyl-10-hydroxycamptothecin,吉米替康 |
Topoisomerase | DNA Damage/DNA Repair |
Chimmitecan ((S)-9-Allyl-10-hydroxycamptothecin) 是一种topoisomerase I 抑制剂,在体内、外表现有效的活性。 | |||
T79883 |
9-Chloromethyl-10-hydroxy-11-F-Camptothecin
|
Topoisomerase | DNA Damage/DNA Repair |
9-Chloromethyl-10-Hydroxy-11-F-Camptothecin是一款喜树碱类衍生化合物,具有DNA拓扑异构酶I (Topo I)抑制活性,应用于癌症治疗的研究领域。 | |||
T79263 |
Antitumor agent-102
|
Topoisomerase | DNA Damage/DNA Repair |
Antitumor agent-102(compound 10)是拓扑异构酶 I(topoisomerase I)抑制剂SN38与葡萄糖转运蛋白(glucose transporter)抑制剂缀合物,专门针对结直肠癌。相较于伊立替康,该化合物在肿瘤组织中可诱导游离SN38的更高浓度。 | |||
T38731 |
Intoplicine dimesylate
RP 60475 dimesylate |
||
Intoplicine (RP 60475) dimesylate is a DNA topoisomerase I and II inhibitor belonging to the 7H-benzo[e]pyrido[4,3-b]indole series. It exhibits a strong affinity for DNA (K A = 2 x 10^5 /M), resulting in increased linear DNA length. | |||
T36695 |
TAS-103
|
||
TAS-103 is a dual inhibitor of DNA topoisomerase I/II, used for cancer research. TAS-103 is a dual inhibitor of DNA topoisomerase I/II. TAS-103 (0.1-10 μM) is active on CCRF-CEM cells, with an IC50 value of 5 nM. TAS-103 (0.1 μM) significantly increases levels of topo IIα FITC immunofluorescence in individual CCRF-CEM cells[1]. TAS-103 (0.01-1 μM) is highly cytotoxic to Lewis lung carcinoma (LLC) cells, and Liposomal TAS-103 is almost as active as free TAS-103[2]. TAS-103 inhibits the viability ... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T2764 |
(S)-10-Hydroxycamptothecin
10-羟喜树碱,10-羟基喜树碱,10-Hydroxycamptothecin,10-HCPT |
Apoptosis; Topoisomerase | Apoptosis; DNA Damage/DNA Repair |
(S)-10-Hydroxycamptothecin (10-HCPT) 是一种从喜树中分离的 DNA 拓扑异构酶 I 抑制剂。它显著诱导细胞凋亡,可研究肝癌、胃癌、结肠癌和白血病。 |